Literature DB >> 30271732

Implementation of the 'Test and Treat' policy for newly diagnosed people living with HIV in Zimbabwe in 2017.

A Rufu1, V T S Chitimbire1, C Nzou1, C Timire2,3, P Owiti4,5, A D Harries5,6, T Apollo7.   

Abstract

Setting: Sixteen mission hospitals in Zimbabwe that are implementing the 'Test and Treat' programme for people living with the human immunodeficiency virus (HIV).
Objectives: To assess linkages of HIV diagnosis to care and treatment, time taken from being diagnosed with HIV infection to initiation of antiretroviral therapy (ART) and 3-month programmatic outcomes for those starting ART. Design: Cross-sectional study using secondary data.
Results: Among 972 people newly diagnosed with HIV, 915 (94%) enrolled for HIV care and 771 (79%) were initiated on ART. Enrolment in care and initiation on ART on the same day as testing occurred in respectively 864 (89%) and 628 (65%) newly diagnosed patients. Over 80% of those who underwent HIV testing in maternal and child health departments initiated ART on the same day. Of the 144 (16%) people in care who were not initiated on ART, the principal reason in 102 (71%) was being transferred out. Most patients (90%) on ART were retained in care at 3 months, with transfer out accounting for most of the remainder.
Conclusion: The 'Test and Treat' approach was feasible and successful in getting newly HIV-infected people initiated early on ART. More research is needed to better understand the processes, benefits and potential risks.

Entities:  

Keywords:  ART initiation; SORT IT; maternal and child health; retention in care; same-day start of ART

Year:  2018        PMID: 30271732      PMCID: PMC6147065          DOI: 10.5588/pha.18.0030

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  13 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Bull World Health Organ       Date:  2007-11       Impact factor: 9.408

2.  Critical considerations for adopting the HIV 'treat all' approach in Zimbabwe: is the nation poised?

Authors:  K C Takarinda; A D Harries; T Mutasa-Apollo
Journal:  Public Health Action       Date:  2016-02-11

3.  False starts in 'test and start': a qualitative study of reasons for delayed antiretroviral therapy in Swaziland.

Authors:  Christopher Pell; Eva Vernooij; Nelisiwe Masilela; Njabulo Simelane; Fortunate Shabalala; Ria Reis
Journal:  Int Health       Date:  2018-03-01       Impact factor: 2.473

Review 4.  Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.

Authors:  Darshini Govindasamy; Nathan Ford; Katharina Kranzer
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

5.  Health facility challenges to the provision of Option B+ in western Kenya: a qualitative study.

Authors:  Anna Helova; Eliud Akama; Elizabeth A Bukusi; Pamela Musoke; Wafula Z Nalwa; Thomas A Odeny; Maricianah Onono; Sydney A Spangler; Janet M Turan; Iris Wanga; Lisa L Abuogi
Journal:  Health Policy Plan       Date:  2017-03-01       Impact factor: 3.344

6.  'Lost to follow up': rethinking delayed and interrupted HIV treatment among married Swazi women.

Authors:  Thandeka T T Dlamini-Simelane; Eileen Moyer
Journal:  Health Policy Plan       Date:  2017-03-01       Impact factor: 3.344

7.  Central nervous system immune reconstitution inflammatory syndrome.

Authors:  Nathan Bahr; David R Boulware; Suzaan Marais; James Scriven; Robert J Wilkinson; Graeme Meintjes
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

8.  False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes.

Authors:  Leslie Shanks; Derryck Klarkowski; Daniel P O'Brien
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  What happens to patients on antiretroviral therapy who transfer out to another facility?

Authors:  Joseph Kwong-Leung Yu; Teck-Siang Tok; Jih-Jin Tsai; Wu-Shou Chang; Rose K Dzimadzi; Ping-Hsiang Yen; Simon D Makombe; Amon Nkhata; Erik J Schouten; Kelita Kamoto; Anthony D Harries
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

10.  Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.

Authors:  Collins C Iwuji; Joanna Orne-Gliemann; Joseph Larmarange; Nonhlanhla Okesola; Frank Tanser; Rodolphe Thiebaut; Claire Rekacewicz; Marie-Louise Newell; Francois Dabis
Journal:  PLoS Med       Date:  2016-08-09       Impact factor: 11.069

View more
  12 in total

1.  Same-day antiretroviral treatment (ART) initiation and associated factors among HIV positive people in Northwest Ethiopia: baseline characteristics of prospective cohort.

Authors:  Nurilign Abebe Moges; Olubukola Adeponle Adesina; Micheal A Okunlola; Yemane Berhane
Journal:  Arch Public Health       Date:  2020-09-22

2.  Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia.

Authors:  Lami Bayisa; Abilo Tadesse; Mebratu Mitiku Reta; Ejigu Gebeye
Journal:  HIV AIDS (Auckl)       Date:  2020-09-24

3.  HIV testing and ART initiation in people who inject drugs and are placed on methadone in Kachin State, Myanmar.

Authors:  N Lum; K T Wai; A M C Thar; K L Show; A D Harries; N M A Wann; S Hone; H N Oo
Journal:  Public Health Action       Date:  2020-03-21

4.  Factors Influencing Rapid Antiretroviral Therapy Initiation at Four eThekwini Clinics, KwaZulu-Natal, South Africa.

Authors:  Sabina M Govere; Chester Kalinda; Moses J Chimbari
Journal:  AIDS Behav       Date:  2021-11-15

5.  Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data.

Authors:  Rivka R Lilian; Kate Rees; James A McIntyre; Helen E Struthers; Remco P H Peters
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

6.  Health provider perspectives on the implementation of the same-day-ART initiation policy in the Gauteng province of South Africa.

Authors:  Dorina Onoya; Idah Mokhele; Tembeka Sineke; Bulelwa Mngoma; Aneesa Moolla; Marnie Vujovic; Jacob Bor; Jonas Langa; Matthew P Fox
Journal:  Health Res Policy Syst       Date:  2021-01-06

7.  Anti-retroviral therapy after "Treat All" in Harare, Zimbabwe: What are the changes in uptake, time to initiation and retention?

Authors:  Takura Matare; Hemant Deepak Shewade; Ronald T Ncube; Kudzai Masunda; Innocent Mukeredzi; Kudakwashe C Takarinda; Janet Dzangare; Gloria Gonese; Bekezela B Khabo; Regis C Choto; Tsitsi Apollo
Journal:  F1000Res       Date:  2020-04-24

8.  Feasibility of implementing same-day antiretroviral therapy initiation during routine care in Ekurhuleni District, South Africa: Retention and viral load suppression.

Authors:  Nolundi Mshweshwe-Pakela; Bhakti Hansoti; Tonderai Mabuto; Deanna Kerrigan; Griffiths Kubeka; Elizabeth Hahn; Salome Charalambous; Christopher J Hoffmann
Journal:  South Afr J HIV Med       Date:  2020-08-20       Impact factor: 2.744

9.  Rapid antiretroviral initiation among Thai youth living with HIV in the National AIDS programme in the era of treatment at any CD4 cell count: a national registry database study.

Authors:  Sirinya Teeraananchai; Stephen J Kerr; Panthep Khananuraksa; Kiat Ruxrungtham; Thanyawee Puthanakit
Journal:  J Int AIDS Soc       Date:  2020-09       Impact factor: 5.396

10.  Trends of HIV-Related Cancer Mortality between 2001 and 2018: An Observational Analysis.

Authors:  Chinmay Jani; Omar Al Omari; Harpreet Singh; Alexander Walker; Kripa Patel; Christian Mouchati; Amr Radwan; Zuha Pandit; Georgina Hanbury; Conor Crowley; Dominic C Marshall; Richard Goodall; Joseph Shalhoub; Justin D Salciccioli; Umit Tapan
Journal:  Trop Med Infect Dis       Date:  2021-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.